|
π
|
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
81 auth.
I. Puzanov,
A. Diab,
K. Abdallah,
C. Bingham,
C. Brogdon,
R. Dadu,
L. Hamad,
S. Kim,
M. Lacouture,
N. LeBoeuf,
D. Lenihan,
C. Onofrei,
V. Shannon,
R. Sharma,
A. Silk,
...
D. Skondra,
M. SuarezβAlmazor,
Y. Wang,
K. Wiley,
H. Kaufman,
M. Ernstoff,
J. Anderson,
Deborah Arrindell,
S. Andrews,
J. Ballesteros,
J. Boyer,
Daniel S Chen,
David Chonzi,
I. Cotarla,
R. Cunha,
M. Davies,
M. Dawson,
A. Dicker,
L. Eifler,
Andrew D. Ferguson,
C. Ferlini,
S. Frankel,
W. Go,
Celestine G. Gochett,
J. Goldberg,
P. Goncalves,
T. Goswami,
Nancy C. Gregory,
J. Gulley,
V. Hayreh,
Nicole Helie,
William C. Holmes,
J. hsu,
R. Ibrahim,
C. Larocca,
K. Lehman,
S. Ley-Acosta,
O. Lambotte,
J. Luke,
J. Mcclure,
E. Michelon,
Mary C. Nakamura,
K. Patel,
B. Piperdi,
Z. Rasheed,
D. Reshef,
J. Riemer,
C. Robert,
M. Sarkeshik,
Ann Saylors,
J. Schreiber,
K. Shafer-Weaver,
W. Sharfman,
E. Sharon,
R. Sherry,
C. Simonson,
C. Thomas,
John A Thompson,
E. Trehu,
D. Tresnan,
M. Turner,
Darshan Wariabharaj,
I. Waxman,
L. Wood,
Lin Zhang,
P. Zheng
|
10 |
2017 |
10
π
|
|
π
|
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
31 auth.
P. Nghiem,
S. Bhatia,
E. Lipson,
R. Kudchadkar,
Natalie J. Miller,
L. Annamalai,
S. Berry,
E. Chartash,
A. Daud,
S. Fling,
P. Friedlander,
H. Kluger,
H. Kohrt,
Lisa M Lundgren,
K. Margolin,
...
A. Mitchell,
T. Olencki,
D. Pardoll,
S. Reddy,
E. Shantha,
W. Sharfman,
E. Sharon,
L. Shemanski,
M. Shinohara,
J. Sunshine,
J. Taube,
John A Thompson,
S. Townson,
J. Yearley,
S. Topalian,
M. Cheever
|
10 |
2016 |
10
π
|
|
π
|
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
53 auth.
S. Patel,
M. Othus,
Yuanbin Chen,
G. Wright,
K. Yost,
John R Hyngstrom,
S. Hu-Lieskovan,
C. Lao,
L. Fecher,
T. Truong,
Jennifer Eisenstein,
S. Chandra,
J. A. Sosman,
K. Kendra,
Richard C Wu,
...
C. Devoe,
G. Deutsch,
A. Hegde,
M. Khalil,
A. Mangla,
A. Reese,
M. Ross,
A. Poklepovic,
G. Phan,
A. Onitilo,
Demet YaΕar,
Benjamin Powers,
G. Doolittle,
G. In,
Niels Kokot,
G. Gibney,
M. Atkins,
M. Shaheen,
J. Warneke,
A. Ikeguchi,
J. E. Najera,
B. Chmielowski,
J. Crompton,
J. Floyd,
E. Hsueh,
K. Margolin,
W. Chow,
K. Grossmann,
E. Dietrich,
V. Prieto,
M. Lowe,
E. Buchbinder,
John M. Kirkwood,
L. Korde,
J. Moon,
E. Sharon,
V. Sondak,
A. Ribas
|
8 |
2023 |
8
π
|
|
π
|
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
31 auth.
P. Nghiem,
S. Bhatia,
E. Lipson,
W. Sharfman,
R. Kudchadkar,
A. Brohl,
P. Friedlander,
A. Daud,
H. Kluger,
S. Reddy,
B. Boulmay,
A. Riker,
M. Burgess,
B. Hanks,
T. Olencki,
...
K. Margolin,
Lisa M Lundgren,
A. Soni,
N. Ramchurren,
C. Church,
Song Y Park,
M. Shinohara,
Bob A. Salim,
J. Taube,
S. Bird,
N. Ibrahim,
S. Fling,
B. Homet Moreno,
E. Sharon,
M. Cheever,
S. Topalian
|
8 |
2018 |
8
π
|
|
π
|
Current Landscape of Immunotherapy in Breast Cancer: A Review.
22 auth.
S. Adams,
M. Gatti-Mays,
K. Kalinsky,
L. Korde,
E. Sharon,
L. Amiri-Kordestani,
H. Bear,
H. McArthur,
E. Frank,
J. Perlmutter,
...
D. Page,
B. Vincent,
J. Hayes,
J. Gulley,
J. Litton,
G. Hortobagyi,
S. Chia,
I. Krop,
J. White,
J. Sparano,
M. Disis,
E. Mittendorf
|
8 |
2019 |
8
π
|
|
π
|
Major Cancer Regressions in Mesothelioma After Treatment with an Anti-Mesothelin Immunotoxin and Immune Suppression
11 auth.
R. Hassan,
Andrew C. Miller,
E. Sharon,
Anish Thomas,
J. Reynolds,
A. Ling,
...
R. Kreitman,
M. Miettinen,
S. Steinberg,
D. Fowler,
I. Pastan
|
7 |
2013 |
7
π
|
|
π
|
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
16 auth.
P. Brown,
Lingyun Ji,
Xinxin Xu,
M. Devidas,
L. Hogan,
M. Borowitz,
E. Raetz,
G. Zugmaier,
E. Sharon,
M. Bernhardt,
...
S. Terezakis,
L. Gore,
J. Whitlock,
M. Pulsipher,
S. Hunger,
M. Loh
|
7 |
2021 |
7
π
|
|
π
|
A Phase II Basket Trial of Dual AntiβCTLA-4 and AntiβPD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
22 auth.
S. Patel,
M. Othus,
Y. Chae,
F. Giles,
D. Hansel,
Preet Paul Singh,
A. Fontaine,
M. Shah,
A. Kasi,
Tareq Al Baghdadi,
...
M. Matrana,
Z. Gatalica,
W. Korn,
J. Hayward,
C. McLeod,
Helen X Chen,
E. Sharon,
E. Mayerson,
C. Ryan,
M. Plets,
C. Blanke,
R. Kurzrock
|
7 |
2020 |
7
π
|
|
π
|
Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
9 auth.
R. Hassan,
S. Cohen,
M. Phillips,
I. Pastan,
E. Sharon,
R. Kelly,
...
C. Schweizer,
S. Weil,
D. Laheru
|
7 |
2010 |
7
π
|
|
π
|
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
25 auth.
H. Kluger,
H. Tawbi,
M. Ascierto,
M. Bowden,
M. Callahan,
E. Cha,
Helen X. Chen,
C. Drake,
D. Feltquate,
R. Ferris,
J. Gulley,
Shilpa Gupta,
R. Humphrey,
T. Lavallee,
D. Le,
...
Vanessa M Hubbard-Lucey,
V. Papadimitrakopoulou,
M. Postow,
E. Rubin,
E. Sharon,
J. Taube,
S. Topalian,
R. Zappasodi,
M. Sznol,
R. Sullivan
|
7 |
2020 |
7
π
|
|
π
|
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
21 auth.
T. Uldrick,
P. Goncalves,
M. Abdul-Hay,
A. Claeys,
B. Emu,
M. Ernstoff,
S. Fling,
L. Fong,
J. Kaiser,
Andreanne Lacroix,
...
Steve Y Lee,
Lisa M Lundgren,
K. Lurain,
Christopher H Parsons,
Sharavi Peeramsetti,
R. Ramaswami,
E. Sharon,
M. Sznol,
C. Wang,
R. Yarchoan,
M. Cheever
|
7 |
2019 |
7
π
|
|
π
|
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and SΓ©zary Syndrome: A Multicenter Phase II Study.
33 auth.
M. Khodadoust,
A. Rook,
P. Porcu,
F. Foss,
A. Moskowitz,
A. Shustov,
S. Shanbhag,
L. Sokol,
S. Fling,
N. Ramchurren,
R. Pierce,
Asa Davis,
Richard Shine,
Shufeng Li,
Sophia Fong,
...
Jinah Kim,
Yi Yang,
W. Blumenschein,
J. Yearley,
Biswajit Das,
R. Patidar,
V. Datta,
Erin N. Cantu,
Justine N. McCutcheon,
C. Karlovich,
P. Williams,
Priyanka B Subrahmanyam,
H. Maecker,
S. Horwitz,
E. Sharon,
H. Kohrt,
M. Cheever,
Youn H. Kim
|
7 |
2020 |
7
π
|
